ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,528,000 | -53.7% | 227,600 | -72.7% | 0.27% | -60.4% |
| Q3 2019 | $35,692,000 | +606.1% | 834,313 | +948.0% | 0.68% | +767.9% |
| Q2 2019 | $5,055,000 | -2.7% | 79,607 | +17.8% | 0.08% | +25.8% |
| Q2 2018 | $5,197,000 | -56.3% | 67,605 | -60.1% | 0.06% | -59.2% |
| Q4 2016 | $11,903,000 | -0.9% | 169,300 | 0.0% | 0.15% | +10.9% |
| Q3 2016 | $12,010,000 | +45.0% | 169,300 | 0.0% | 0.14% | +59.3% |
| Q2 2016 | $8,280,000 | +1.9% | 169,300 | +32.0% | 0.09% | +1.2% |
| Q1 2016 | $8,123,000 | – | 128,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |